Scientific Publications: 2001

  1. Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, LeungL, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L. The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies Against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region. J Virol, 2001;75:5526-5540
  2. Peel SA. The ABC Transporter Genes of Plasmodiun Falciparum and Drug Resistance. Drug Resistance Updates 2001; 4:66-74
  3. De Souza MS, Trichavaroj R, Sriplienchan S, Buapunth P, Renzullo PO, Chuenchitra C, Birx DL, Robb ML, Brown AE. Detection and Quantification of HIV Type 1 RNA in Nasopharyngeal Washes from HIV-Infected Subjects. AIDS Res and Human Retroviruses 2001;17:229-232
  4. Hoelscher M, Kim B, Maboko L, Mhalu F, von Sonnenburg F, Birx DL, McCutchan FE, UNAIDS Network for HIV Isolation and Characterization. High Proportion of Unrelated HIV-1 Intersubtype Recombinants in the Mbeya Region of Southwest Tanzania. AIDS 2001;15:1461-1470
  5. Carr J, Torimiro JN, Wolfe ND, Eitel MN, Kim B, Sanders-Buell E, Jagodzinski LL, Gotte D, Burke DS, Birx DL, McCutchan FE. The AG Recombinant IbNG and Novel Strains of Group M HIV-1 Are Common in Cameroon. Virology 2001;286:168-181
  6. Renzullo PO, Sateren WB, Garner RP, MilazzaMJ, Birx DL, McNeil JG. HIV-1 Seroconversion in United States Army Active Duty Personnel, 1985-1999. AIDS 2001;15:1569-1574
  7. Trichavaro R, de Souza MS, Buapunth P, Markawitz L, Sukwit S, Nitayaphan S, Brown A. HIV Viral Load in Thai Men and Women With Subtype E Infections. J Acquir Immun Deficiency Hum Retrovirology 2001;26:345-347
  8. Kim JH, Mascola JR, Ratto-Kim S, VanCott TC, Loomis-Price L, Cox JH, Michael NL, Jagodzinski L, Hawkes C, Mayers D, Gilliam BL, Birx DL, Robb ML. Selective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses During Prolonged, Successful Drug Therapy of HIV Infection. AIDS Res Hum Retroviruses 2001;17:1021-1034
  9. Tovanabutra S, Polonis V, De Souza M, Trichavaro R, Chanbancherd P, Kim B, Sander-Buell E, Nitayaphan S, Brown A, Robb MR, Birx DL, McCutchan FE, Car JK. First CRF01_AE/B Recombinant of HIV-1 is Found In Thailand. AIDS 2001;15:1063-5
  10. Yu XF, Liu W, Chen J, Kong W, Liu B, Yang J, Liang F, McCutchan F, Piyasirisilp S, Lai S. Rapid disemination of a novel B/C recombinant HIV-1 among injection drug users in southern China. AIDS 2001;15:523-538
  11. Dowsett GW. Sustaining safe sex: sexual practices, HIV and social context. AIDS 1993; 7(suppl 1):S257-S262
  12. Birx D. Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1. AIDS 2001;15:W1-W25
  13. Belyakov, I., Wang, J., Koka, R., Ahlers, J., Snyder, J., Tse, R., Cox, J., Gibbs, J., Margulies, D. and Berzofsky, J., Activating CTL precursors to reveal CTL function without skewing the repertoire by in vitro expansion. Eur J Immunol 2001. 31: p3557-3566
  14. Brown, A., Dolan, M., Michael, N., Zhou, S., Perfetto, S., Hawkes, C., Robb, M., Lane, J., Mayers, D., McNeil, J., Malone, J., Garner, R. and Birx, D., Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation. Mil Med 2001. 166: p571-576
  15. Carr, J., Avila, M., Gomez, C. M., Salomon, H., Hierholzer, J., Watanaveeradej, V., Pando, M., Negrete, M., Russell, K., Sanchez, J., Birx, D., Andrade, R., Vinoles, J. and McCutchan, F., Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001. 15: pF41-47
  16. Chen, X., Scala, G., Quinto, I., Liu, W., Chun, T., Justement, J., Cohen, O., VanCott, T, Iwanicki, M., Lewis, M., Greenhouse, J., Barry, T., Venzon, D. and Fauci, A., Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat Med 2001. 7: p1225-1231
  17. Cohn, M., Frankel, S., Rugpao, S., Young, M., Willett, G., Tovanabutra, S., Khamboonruang, C., VanCott, T, Bhoopat, L., Barrick, S., Fox, C., Quinn, T., Vahey, M., Nelson, K. and Weissman, D., Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women. J Infect Dis 2001. 184: p410-417
  18. Gray, R., Wabwire-Mangen, F., Kigozi, G., Sewankambo, N., Serwadda, D., Moulton, L., Quinn, T., O'Brien, K., Meehan, M., Abramowsky, C., Robb, M. and Wawer, M., Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001. 185: p1209-1217
  19. Gray, R., Wawer, M., Brookmeyer, R., Sewankambo, N., Serwadda, D., Wabwire-Mangen, F., Lutalo, T., Li, X., VanCott, T and Quinn, T., Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001. 357: p1149-1153
  20. Harrigan, P., Montaner, J., Wegner, S., Verbiest, W., Miller, V., Wood, R. and Larder, B., World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing. AIDS 2001. 15: p1671-1677
  21. Hioe, C., Tuen, M., Chien, P., Jones, G., Ratto-Kim, S., Norris, P., Moretto, W., Nixon, D., Gorny, M. and Zolla-Pazner, S., Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120. J Virol 2001. 75: p10950-10957
  22. Ioannidis, J., Rosenberg, P., Goedert, J., Ashton, L., Benfield, T., Buchbinder, S., Coutinho, R., Eugen-Olsen, J., Gallart, T., Katzenstein, T., Kostrikis, L., Kuipers, H., Louie, L., Mallal, S., Margolick, J., Martinez, O., Meyer, L., Michael, N., Operskalski, E., Pantaleo, G., Rizzardi, G., Schuitemaker, H., Sheppard, H., Stewart, G., Theodorou, I., Ullum, H., Vicenzi, E., Vlahov, D., Wilkinson, D., Workman, C., Zagury, J. and O'Brien, T., Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001. 135: p782-795
  23. Janini, M., Rogers, M., Birx, D. and McCutchan, F., Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol 2001. 75: p7973-7986
  24. Kantakamalakul, W., Cox, J., Kositanont, U., Siritantikorn, S., Limbach, K., Birx, D., Thongcharoen, P. and Puthavathana, P., Cytotoxic T lymphocyte responses to vaccinia virus antigens but not HIV-1 subtype E envelope protein seen in HIV-1 seronegative Thais. Asian Pac J Allergy Immunol 2001. 19: p17-22
  25. Marovich, M., Grouard-Vogel, G., Louder, M., Eller, M., Sun, W., Wu, S., Putvatana, R., Murphy, G., Tassaneetrithep, B., Burgess, T., Birx, D., Hayes, C., Schlesinger-Frankel, S. and Mascola, J., Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc 2001. 6: p219-224
  26. Marovich, M., Lira, R., Shepard, M., Fuchs, G., Kruetzer, R., Nutman, T. and Neva, F., Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment. Clin Infect Dis 2001. 33: p1076-1079
  27. McDonald, R., Chang, G. and Michael, N., Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1. J Hum Virol 2001. 4: p179-187
  28. Polonis, V., De, S. M., Chanbancherd, P., Chantakulkij, S., Jugsudee, A., Loomis-Price, L., Vancott, T., Garner, R., Markowitz, L., Brown, A. and Birx, D., HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies. AIDS Res Hum Retroviruses 2001. 17: p69-79
  29. Reinis, M., Bruckova, M., Graham, R., Vandasova, J., Stankova, M. and Carr, J., Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic. AIDS Res Hum Retroviruses 2001. 17: p1305-1310
  30. Van Harmelen J., Williamson, C., Kim, B., Morris, L., Carr, J., Karim, S. and McCutchan, F., Characterization of full-length HIV type 1 subtype C sequences from South Africa. AIDS Res Hum Retroviruses 2001. 17: p1527-1531
  31. Wallace, M., Persing, D., McCutchan, J., Magara, J., Nelson, J., Heaton, R., Tasker, S. and Grant, I., Bartonella henselae serostatus is not correlated with neurocognitive decline in HIV infection. Scand J Infect Dis 2001. 33: p593-595
  32. Wallace, M., Tasker, S., Shinohara, Y., Hill, H., Chapman, G. and Miller, L., The changing economics of HIV care. AIDS Patient Care STDS 2001. 15: p25-29.
  33. Cunto-Amesty G, Dam TK, Luo P, Monzavi-Karbassi B, Brewer CF, VanCott TC, Kieber-Emmons T. Directing the Immune Response to Carbohydrate Antigens. 2001. J. Biol. Chem. 276:3-490-8.
  34. Nau, M., L. Emerson. R. Martin, D. Kyle, D. Wirth, M. Vahey. 2001. Technical Assessment of the Affymetrix Yeast Expression GeneChip YE6100 Platform in a Heterologous Model of Genes that Confer Resistance to Antimalarial Drugs in Yeast. J. Clinical Microbiol. Journal of Clinical Microbiology. 38:1901-1908.
  35. Cohn, M., S. Frankel, S Rugpao, M. Young, G. Wollett, S. Tovanabutra, V. Suriyanon, T. Van Cott, L. Bhoopat, S. Barrick, C. Fox, T. Quinn, M. Vahey, K. Nelson, D. Weissman. 2001. Chronic Inflammation with Increased HIV RNA Expression in the Vaginal Epithelium of HIV Infected Thai Women. J. Infect Dis. 184(4):410-417.
  36. Nau ME, Emerson LR, Martin RK, Kyle DE, Wirth DF, Vahey M. Technical Assessment of the Affymetrix Yeast Expression Gene Chip YE6100 Platform in a Heterologous Model of Genes That Cofer Ressistance to Antimalarial Drugs in Yeast. J Clin Microbiol 2001;38:1901-1908